An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide

We have previously identified the novel Cancer/Testis antigen PASD1 by immunoscreening a testis library with pooled acute myeloid leukemia (AML) patient sera. To develop a cytotoxic T lymphocyte (CTL)-inducing vaccine, we have now investigated the carboxy-terminal region, known to contain serologica...

Full description

Bibliographic Details
Main Authors: Hardwick, Nicola (Author), Buchan, Sarah L. (Author), Ingram, Wendy (Author), Khan, Ghazala (Author), Vittes, Gisella E. (Author), Rice, Jason (Author), Pulford, Karen (Author), Mufti, Ghulam (Author), Stevenson, Freda (Author), Guinn, Barbara-ann (Author)
Format: Article
Language:English
Published: 2013-07-15.
Subjects:
Online Access:Get fulltext